Alliancebernstein L.P. Procept Bio Robotics Corp Transaction History
Alliancebernstein L.P.
- $300 Billion
- Q3 2025
A detailed history of Alliancebernstein L.P. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,419,784 shares of PRCT stock, worth $102 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,419,784
Previous 2,156,856
58.55%
Holding current value
$102 Million
Previous $124 Million
1.76%
% of portfolio
0.04%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding PRCT
# of Institutions
274Shares Held
49.1MCall Options Held
282KPut Options Held
384K-
Vanguard Group Inc Valley Forge, PA5.21MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$103 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.05MShares$60.9 Million0.04% of portfolio
-
Westfield Capital Management CO LP Boston, MA1.97MShares$58.5 Million0.32% of portfolio
-
Chicago Capital, LLC1.57MShares$46.6 Million1.39% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.32B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...